Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prosarix is a computational drug discovery company based in Cambridge, UK, that specializes in the development and application of advanced informatics and structural biology tools. The company's core technology, the ProtoS platform, enables the rapid identification and optimization of small molecule leads by integrating protein structure data with chemical space exploration. Prosarix operates primarily through strategic collaborations and service agreements with pharmaceutical and biotechnology companies to accelerate their early-stage drug discovery programs. Their expertise spans virtual screening, lead generation, and the analysis of complex protein-ligand interactions to identify novel, synthetically accessible drug candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prosarix.